Safety, Tolerability and Efficacy of TV-1106 in Adults With Growth Hormone Deficiency
Study Title
- Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency
Teva Identifier
- TV1106-GHD-201 | 2012-004975-37
ClinicalTrials.gov Identifier
- NCT01811576
Study Status
- Completed
Trial Condition(s)
- Growth Hormone Deficiency
Interventions
- Drug: TV-1106 | Drug: Recombinant human growth hormone
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 23 Years to 65 Years
Trial Duration
- March 31, 2013 - August 5, 2013
Phase
- Phase 2
Study Type
Interventional
